Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuya Shimizu is active.

Publication


Featured researches published by Shuya Shimizu.


Journal of Gastroenterology and Hepatology | 2013

Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction

Shuya Shimizu; Itaru Naitoh; Takahiro Nakazawa; Kazuki Hayashi; Katsuyuki Miyabe; Hiromu Kondo; Michihiro Yoshida; Hiroaki Yamashita; Shuichiro Umemura; Yasuki Hori; Hirotaka Ohara; Takashi Joh

Pancreatitis and cholecystitis are major complications after self‐expandable metal stent (SEMS) placement in distal malignant biliary obstruction. We aimed to clarify predictive factors for pancreatitis and cholecystitis after covered SEMS placement.


Journal of Gastroenterology and Hepatology | 2015

Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis

Itaru Naitoh; Takahiro Nakazawa; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Michihiro Yoshida; Shuichiro Umemura; Yasuki Hori; Akihisa Kato; Fumihiro Okumura; Hitoshi Sano; Hirotaka Ohara; Takashi Joh

Comparisons of intraductal ultrasonography (IDUS) findings between primary sclerosing cholangitis (PSC) and IgG4‐related sclerosing cholangitis (IgG4‐SC) have not been elucidated. We aimed to clarify the differences in transpapillary IDUS findings between PSC and IgG4‐SC.


Scandinavian Journal of Gastroenterology | 2012

Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer

Itaru Naitoh; Takahiro Nakazawa; Kazuki Hayashi; Fumihiro Okumura; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Michihiro Yoshida; Hiroaki Yamashita; Hirotaka Ohara; Takashi Joh

Abstract Objective. Autoimmune pancreatitis (AIP) needs to be differentiated from pancreatic cancer (PC). We aimed to clarify the findings specific for AIP by comparing the clinical differences between mass-forming AIP and PC. Material and methods. We retrospectively compared 36 patients with mass-forming AIP and 60 with PC without metastasis regarding clinical, imaging, serological, histological differences and other organ involvement (OOI). We evaluated the sensitivity, specificity and accuracy of these findings for the differential diagnosis between AIP and PC. Results. The findings 100% specific for AIP were a capsule-like rim on computed tomography (CT), skipped lesion of main pancreatic duct (MPD) on endoscopic retrograde pancreatography (ERP) or magnetic resonance cholangiopancreatography (MRCP), γ-globulin > 2 g/dl, OOI (extrapancreatic biliary stricture, salivary gland swelling and retroperitoneal fibrosis) and ruling out PC by histopathological findings of endoscopic ultrasonography-guided fine-needle aspiration. The findings over 90% specific were IgG4 > 280 mg/dl (98%), IgG > 1800 mg/dl (97%), maximal diameter of upstream MPD < 5 mm on MRCP (95%) and IgG4 > 135 mg/dl (94%), respectively. Conclusions. Clinical, imaging, serological, histological findings and OOI differed between mass-forming AIP and PC. Capsule-like rim on CT, skipped lesion of MPD on ERP or MRCP, IgG4 > 280 mg/dl, and OOI were highly specific findings for AIP. These findings are useful in the differential diagnosis of mass-forming AIP from PC.


Oncotarget | 2015

Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2

Akihisa Kato; Aya Naiki-Ito; Takahiro Nakazawa; Kazuki Hayashi; Itaru Naitoh; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Michihiro C. Yoshida; Shuichiro Umemura; Yasuki Hori; Toshio Mori; Masahiro Tsutsumi; Toshiya Kuno; Shugo Suzuki; Hiroyuki Kato; Hirotaka Ohara; Takashi Joh; Satoru Takahashi

Despite progress in clinical cancer medicine in multiple fields, the prognosis of pancreatic cancer has remained dismal. Recently, chemopreventive strategies using phytochemicals have gained considerable attention as an alternative in the management of cancer. The present study aimed to evaluate the chemopreventive effects of resveratrol (RV) and apocynin (AC) in N-Nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamster. RV- and AC-treated hamsters showed significant reduction in the incidence of pancreatic cancer with a decrease in Ki-67 labeling index in dysplastic lesions. RV and AC suppressed cell proliferation of human and hamster pancreatic cancer cells by inhibiting the G1 phase of the cell cycle with cyclin D1 downregulation and inactivation of AKT-GSK3β and ERK1/2 signaling. Further, decreased levels of GSK3βSer9 and ERK1/2 phosphorylation and cyclin D1 expression in the nuclear fraction were observed in cells treated with RV or AC. Nuclear expression of phosphorylated GSK3βSer9 was also decreased in dysplastic lesions and adenocarcinomas of hamsters treated with RV or AC in vivo. These results suggest that RV and AC reduce phosphorylated GSK3βSer9 and ERK1/2 in the nucleus, resulting in inhibition of the AKT-GSK3β and ERK1/2 signaling pathways and cell cycle arrest in vitro and in vivo. Taken together, the present study indicates that RV and AC have potential as chemopreventive agents for pancreatic cancer.


Journal of Gastroenterology and Hepatology | 2014

Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients

Yasuki Hori; Itaru Naitoh; Takahiro Nakazawa; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Michihiro Yoshida; Hiroaki Yamashita; Shuichiro Umemura; Tessin Ban; Fumihiro Okumura; Hitoshi Sano; Hiroki Takada; Takashi Joh

The opportunities of endoscopic retrograde cholangiopancreatography (ERCP)‐related procedure for hemodialysis (HD) patients have been increasing recently. However, the complication rate of ERCPs in HD patients has not been evaluated sufficiently. We aimed to clarify the feasibility of ERCPs in HD patients.


Pancreas | 2013

Clinical evaluation of international consensus diagnostic criteria for type 1 autoimmune pancreatitis in comparison with Japanese diagnostic criteria 2011.

Itaru Naitoh; Takahiro Nakazawa; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Michihiro C. Yoshida; Hiroaki Yamashita; Shuichiro Umemura; Yasuki Hori; Hirotaka Ohara; Takashi Joh

Objectives The objective of this study was to evaluate the International Consensus Diagnostic Criteria (ICDC) for type 1 autoimmune pancreatitis (AIP) in comparison with the Japanese criteria 2011 (JPS2011). Methods We retrospectively investigated the usefulness of ICDC in comparison with JPS2011 in 64 patients with AIP and 90 patients with pancreatic cancer. Results The sensitivity and specificity of ICDC for AIP were 98.4% (63/64) and 100% (90/90), respectively. The sensitivities and specificities of ductal imaging, serology, other organ involvement, and pancreatic histology were 74.1%, 89.1%, 53.1%, and 26.1% and 94.7%, 94.5%, 100%, and 100%, respectively. On the other hand, the sensitivities and specificities of JPS2011 for AIP were 84.4% (54/64) and 100% (90/90), respectively. The condition of all the 10 patients who were deniable or possible under the JPS2011 could be diagnosed as definitive AIP under the ICDC. The sensitivities and specificities of Japanese criteria 2006, Asian Diagnostic Criteria, and HISORt criteria were 80.6%, 84.4%, and 92.2% and 95.8%, 87.8%, and 100%, respectively. Conclusions The sensitivity and specificity of ICDC are higher than those of previous criteria. The JPS2011 is easy to handle for general practice, and specificity is very high. However, the sensitivity of JPS2011 is lower than that of ICDC, and improvement of sensitivity is to be hoped in the future.


Pancreas | 2013

Intraductal papillary mucinous neoplasm associated with autoimmune pancreatitis.

Itaru Naitoh; Takahiro Nakazawa; Kenji Notohara; Katsuyuki Miyabe; Kazuki Hayashi; Shuya Shimizu; Hiromu Kondo; Michihiro C. Yoshida; Hiroaki Yamashita; Shuichiro Umemura; Hirotaka Ohara; Takashi Joh

raphy from the major duodenal papilla, the DPD appeared via the loop-forming communicating duct called the ansa pancreatica (Fig. 1A). Next, the VPD ascended making a loop cranially, and it joined the DPD again (Fig. 1B). A cyst was enhanced through the DPD. Pancreatography from the minor duodenal papilla showed the entirely dilated DPD and the VPD. A second pancreatography via the catheter deeply inserted into the VPD revealed the DPD, and communication between this VPD and the DPD was clearly demonstrated using a guide wire (Fig. 1C). The DPD connected the DPD at 2 points (Fig. 1D). Both major and minor duodenal papillae were normal, and the cytology of pancreatic juice obtained from the VPD and DPD was negative. On suspicion of chronic pancreatitis or intraductal papillary mucinous neoplasm, he is currently followed up.


Journal of Digestive Diseases | 2016

Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy

Itaru Naitoh; Takahiro Nakazawa; Akihisa Kato; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Michihiro Yoshida; Shuichiro Umemura; Yasuki Hori; Toshiya Kuno; Satoru Takahashi; Hirotaka Ohara; Takashi Joh

The diagnostic yields of endoscopic transpapillary brush cytology and forceps biopsies for malignant biliary strictures (MBS) remain unclear and predictive factors for diagnosis have not been established. We aimed to clarify the diagnostic yields of both methods and the predictive factors


Journal of Gastroenterology and Hepatology | 2015

Stent under-expansion on the procedure day, a predictive factor for poor oral intake after metallic stenting for gastric outlet obstruction.

Yasuki Hori; Itaru Naitoh; Tesshin Ban; Kei Narita; Takahiro Nakazawa; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Michihiro Yoshida; Shuichiro Umemura; Akihisa Kato; Tomonori Yamada; Tomoaki Ando; Takashi Joh

Self‐expandable metallic stents (SEMS) have been widely accepted as palliation therapy for malignant gastric outlet obstruction (GOO). However, the factors predictive of poor oral intake after SEMS placement have not been elucidated sufficiently. We aimed to clarify both the patient and stent‐related predictive factors.


World Journal of Gastroenterology | 2014

Inflammatory bowel disease of primary sclerosing cholangitis:A distinct entity?

Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Hitoshi Sano; Katsuyuki Miyabe; Shuya Shimizu; Takashi Joh

This is a review of the characteristic findings of inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC) and their usefulness in the diagnosis of sclerosing cholangitis. PSC is a chronic inflammatory disease characterized by idiopathic fibrous obstruction and is frequently associated with IBD. IBD-associated with PSC (PSC-IBD) shows an increased incidence of pancolitis, mild symptoms, and colorectal malignancy. Although an increased incidence of pancolitis is a characteristic finding, some cases are endoscopically diagnosed as right-sided ulcerative colitis. Pathological studies have revealed that inflammation occurs more frequently in the right colon than the left colon. The frequency of rectal sparing and backwash ileitis should be investigated in a future study based on the same definition. The cholangiographic findings of immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) are similar to those of PSC. The rare association between IBD and IgG4-SC and the unique characteristics of PSC-IBD are useful findings for distinguishing PSC from IgG4-SC.

Collaboration


Dive into the Shuya Shimizu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takashi Joh

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuki Hori

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge